Annual report / Annual accounts Archives

Xspray Pharma publishes its Annual Report 2023

Xspray Pharma AB (publ) today publishes its Annual Report for the financial year 2023. The Annual Report is attached to this press release and available on the company’s website: https://xspraypharma.com/investors/financial-reports/ An extract from the CEO-letter from Per Andersson, CEO of Xspray Pharma: “Throughout 2023, we continued to make significant progress on the exciting journey toward the […]

Xspray Pharma publishes its Annual Report 2022

Xspray Pharma AB (publ) today publishes its Annual Report for the financial year 2022. The Annual Report is attached to this press release and available on the company’s website: https://xspraypharma.com/investors/financial-reports/ An extract from the CEO-letter from Per Andersson, CEO of Xspray Pharma: “We made important progress during 2022 in completing our first product intended for launch […]

Xspray Pharma publishes its annual report for 2021

“In 2021, we once again confirmed that Xspray Pharma’s unique technology platform can produce amorphous versions of protein kinase inhibitors. Having our processes in place means that we can shorten the development time for new products. I look forward to an intensive and productive 2022, during which Xspray Pharma’s organization will develop and mature, and […]

Xspray Pharma publishes its annual report for 2020

Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) today announces that the company's annual report for the financial year 2020 has been published. “Our HyNap technology is the first of its kind in the world and allows multiple pathways to success. During the year, we established a unique supply chain and strengthened the patent position concurrently […]